Detalhe da pesquisa
1.
Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.
J Urol
; 210(5): 771-777, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37566643
2.
Delayed radical prostatectomy after a period of active surveillance is not associated with the use of secondary treatments compared with immediate prostatectomy.
Prostate
; 82(3): 323-329, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34855239
3.
The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillance.
Prostate
; 82(10): 1068-1074, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35468226
4.
Urologic oncology patient perspectives during COVID-19 treatment delays.
Support Care Cancer
; 30(8): 7015-7020, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583826
5.
Delayed urologic cancer care in the COVID-19 pandemic: Patients' experiences.
Eur J Cancer Care (Engl)
; 31(6): e13677, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35942930
6.
Limitations of abdominopelvic CT and multiparametric MR imaging for detection of lymph node metastases prior to radical prostatectomy.
World J Urol
; 39(3): 779-785, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361876
7.
Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups.
J Urol
; 201(2): 278-283, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195846
8.
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.
BJU Int
; 123(5): 846-853, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30248225
9.
Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies.
Cancer
; 124(4): 698-705, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29131319
10.
Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer.
BJU Int
; 122(1): 50-58, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29388388
11.
Evaluation of a needle disinfectant technique to reduce infection-related hospitalisation after transrectal prostate biopsy.
BJU Int
; 121(2): 232-238, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28796919
12.
Repeat Prostate Biopsy Practice Patterns in a Statewide Quality Improvement Collaborative.
J Urol
; 198(2): 322-328, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28257783
13.
Appropriateness Criteria for Active Surveillance of Prostate Cancer.
J Urol
; 197(1): 67-74, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27422298
14.
A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer.
J Urol
; 197(5): 1222-1228, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27889418
15.
Bladder cancer in 2010: how far have we come?
CA Cancer J Clin
; 60(4): 244-72, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20566675
16.
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Reply.
J Urol
; 206(1): 172-173, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33818132
17.
Notable Outcomes and Trackable Events after Surgery: Evaluating an Uncomplicated Recovery after Radical Prostatectomy.
J Urol
; 196(2): 399-404, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26916722
18.
Evaluation of point-of-care PRO assessment in clinic settings: integration, parallel-forms reliability, and patient acceptability of electronic QOL measures during clinic visits.
Qual Life Res
; 25(3): 575-83, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26373852
19.
Sexual Health Concerns Among Cancer Survivors: Testing a Novel Information-Need Measure Among Breast and Prostate Cancer Patients.
J Cancer Educ
; 31(3): 588-94, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076657
20.
Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy.
Cancer
; 121(22): 4071-9, 2015 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26280815